A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
CLINICAL EXPERIENCES WITH CEFOXITIN IN THE FIELD OF CHRONIC RESPIRATORY TRACT INFECTIONS
慢性気道感染症の急性悪化に対するCefoxitinの使用経験
1978
Chemotherapy
慢性気道感染症の急性悪化に対するCefoxitinの使用経験
Preserved Fulltext
Cefoxitin (CFX) was administered to 14 cases with chronic respiratory tract infections. Excellent results were obtained in 2 cases, good results in 9 cases and unchanged results in 3 cases; the efficacy rate being 80%. In all cases, there were no significant side effects regarding symptoms, hematological analysis and renal and hepatic functional tests. Judging from the clinical results and antimicrobial spectrum, CFX may be a useful drug for respiratory tract infections.
doi:10.11250/chemotherapy1953.26.supplement1_313
fatcat:zevrbeiolrfergxi6sxh6iqfke